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ABSTRACT 
Assessing Endothelial Dysfunction Estimating the Differences Between 
3 Minute and 5 Minute Reactive Hyperemia Stimuli 
Tamiko Saldin 
 
The purpose of this study was to define a lower standard cuff occlusion time to induce 
reactive hyperemia in assessing endothelial dysfunction. In this study, strong evidence was found 
by a novel technique that used oscillometric methods, which supported that 3 minute reactive 
hyperemia was sufficient to elicit a significant difference in arterial compliance from baseline. 
Twenty healthy Cal Poly students were assessed, (n=12 female, n=8 male) aged 22 years old with 
a standard deviation of 2.04 years. Arterial compliance was estimated by measuring the peak-to-
peak oscillations for baseline, 3 minute reactive hyperemia, and 5 minute reactive hyperemia 
tests, with the result being statistical evidence of an increase in arterial compliance after 3 
minutes of cuff occlusion compared to baseline. The peak-to-peak mean for the 3 minute reactive 
hyperemia test was significantly greater than the baseline peak-to-peak mean with p-values less 
than 0.0001. These results support that 3 minute reactive hyperemia is sufficient to assess 
endothelial dysfunction using oscillometry techniques. Endothelial dysfunction is the most 
significant predictor of a major adverse cardiovascular event, so this test can be used as an early 
detection tool for cardiovascular disease and allow patients to find treatment before irreversible 
damage is done to the body. Implementing this test into routine doctor checkups has the potential 
to have a significant effect on cardiovascular disease, which is the leading cause of death 
globally. The currently accepted clinical benchmark performed in hospitals uses high-frequency 
ultrasound with a standard cuff occlusion time of 5 minutes. Although noninvasive, 5 minutes of 
cuff occlusion causes slight discomfort to the patient and is not desirable. This test was improved 
and shortened by using a system based on the oscillometric method of blood pressure 
measurement. By reducing the duration of the test from 5 minute reactive hyperemia to 3 minute 
reactive hyperemia, this will make the procedure practical for an increased number of patients, 
providing a noninvasive option to regularly check for early symptoms of cardiovascular disease. 
 
Keywords: endothelial dysfunction, reactive hyperemia, oscillometry, early diagnosis, 
cardiovascular disease 
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Chapter 1 
INTRODUCTION 
 
1.1 Prevalence of Cardiovascular Disease 
Cardiovascular disease is the global leading cause of death, and is responsible for about one 
in every three deaths [1]. Cardiovascular disease includes any disease affecting the heart and/or 
blood vessels.  Of the deaths attributable to cardiovascular disease, coronary heart disease is the 
leading cause of these deaths (43.8%), followed by stroke (16.8%), high blood pressure (9.4%), 
heart failure (9.0%), diseases of the arteries (3.1%) and other cardiovascular diseases (17.9%) [1]. 
Shown in Figure 1 are the age-adjusted death rates for the leading causes of death in the United 
States from 1978 to 2015 [2]. Heart disease is shown as the highest leading cause of death since 
1958 and continues to be the leading cause of death today.  
 
Figure 1 U.S. Age-Adjusted Death Rates for the Leading Causes of Death, 1958-2015 [2] 
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1.2 Atherosclerosis 
The most common type of heart disease is coronary heart disease [3]. Coronary heart disease 
results from the buildup of fatty plaque in the blood vessels, shown in Figure 2. Plaque buildup, 
otherwise known as atherosclerosis, causes the arteries to narrow and harden, which can damage 
the blood vessel, decrease blood flow, and require the heart to work harder to pump blood. If 
plaque builds up in the arteries supplying blood to the heart, this is known as coronary artery 
disease and can lead to a heart attack. If the plaque builds up in the arteries supplying blood to the 
arms and legs, this is known as peripheral artery disease, and if the plaque builds up in the arteries 
supplying blood to the brain, this is known as carotid artery disease and can lead to stroke. The 
plaque itself could completely occlude the artery, or a portion of the plaque can embolize and 
dislodge itself further downstream, causing several complications.  
  
Figure 2 Atherosclerosis. Healthy artery versus artery with atherosclerosis showing plaque 
buildup and abnormal blood flow. [4] 
Atherosclerosis is typically caused by destructive life habits including unhealthy diet, 
lack of exercise, and smoking [5]. There are currently seven cardiovascular health metrics that 
have been identified as critical in defining ideal cardiovascular health. The metrics were 
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published by the American Heart Association as a goal for 2020, and define poor, intermediate, 
and ideal cardiovascular health for adults greater than 20 years old and children between the ages 
of 12 and 19, summarized in Table 1 [6].  
Table 1 Ideal, Intermediate, and Poor Cardiovascular Health Definitions [6] 
Metric Age 
Cardiovascular health definitions 
Ideal Intermediate Poor 
1. Current 
smoking 
Adults 
> 20 years 
Never or quit > 12 
months ago 
Former ≤ 12 months Yes 
Children 
12 – 19 years 
Never tried, never 
smoked whole 
cigarette 
 
Tried prior 30 
days 
2. Body 
mass index 
Adults 
> 20 years 
< 25 kg/m2 25 – 29.9 kg/m2 ≥ 30 kg/m2 
Children 
12 – 19 years 
< 85th percentile 
85th – 95th 
percentile 
> 95th 
Percentile 
3. Physical 
activity 
 
Adults 
> 20 years 
≥ 150 min/week 
moderate intensity or 
≥ 75 min/week 
vigorous intensity or 
combination 
1 – 149 min/week 
moderate intensity or 
1 – 74 min/week 
vigorous intensity or 
1 – 149 min/week 
moderate + vigorous 
None 
Children 
12 – 19 years 
≥ 60 min of 
moderate- or 
vigorous-intensity 
activity every day 
> 0 and < 60 min of 
moderate or vigorous 
activity every day 
None 
4. Healthy 
diet score 
Adults 
> 20 years 
4 – 5 components 2 – 3 components 
0 – 1 
components 
Children 
12 – 19 years 
4 – 5 components 2 – 3 components 
0 – 1 
components 
5. Total 
cholesterol 
Adults 
> 20 years 
< 200 mg/dL 
200 – 239 mg/dL or 
treated to goal 
≥ 240 mg/dL 
Children 
12 – 19 years 
< 170 mg/dL 170 – 199 mg/dL ≥ 200 mg/dL 
6. Blood 
pressure 
Adults 
> 20 years 
< 120 / < 80 mmHg 
SBP 120 – 139 or 
DBP 80 – 89 mmHg 
or treated to goal 
SBP ≥ 140 or 
DBP ≥ 90 
mmHg 
Children 
12 – 19 years 
< 90th percentile 
90th – 95th 
percentile or 
SBP ≥ 120 or 
DBP ≥ 80 mmHg 
> 95th 
percentile 
7. Fasting 
plasma 
glucose 
Adults 
> 20 years 
< 100 mg/dL 
100–125 mg/dL or 
treated to goal 
≥ 126 mg/dL 
Children 
12 – 19 years 
<100 mg/dL 100–125 mg/dL ≥ 126 mg/dL 
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The timing of the diagnosis of cardiovascular disease plays a crucial factor in the patient’s 
ability to overcome the disease. Typically, the earlier the diagnosis, relative to the stage of the 
disease, the easier it will be for the patient to treat this disease. Treatment can be as simple as 
changing lifestyle habits to healthier options, which may reverse the disease and save the 
patient’s life. If the diagnosis occurs too late in the progression of the disease, treatment may 
include surgery or life-long medications. The ideal diagnosis would occur even before symptoms 
may begin. In order to accomplish this, doctors would routinely use noninvasive procedures to 
check for precursors to cardiovascular disease. To prevent a disease from occurring before serious 
negative symptoms occur is the ultimate goal for the future.  
1.3 Endothelial Dysfunction 
The human body consists of an extensive vascular system, which must be able to deliver 
sufficient blood where needed by adapting to changes within the body. A blood vessel consists of 
multiple layers, with the inner lining being the endothelium. The endothelium sends signals to the 
smooth muscle cells located in the media to expand or constrict, which changes the lumen 
diameter and maintains vascular tone. The dominating signal in this pathway is the release of 
nitric oxide (NO), which causes smooth muscle cells to relax and thus dilate the vessel. 
Endothelial dysfunction (ED) occurs when the release of NO gets inhibited, and the endothelium 
is unable to properly maintain vascular homeostasis due to narrowing or stiffening of the arteries. 
ED has become a widely known precursor to cardiovascular disease. 
1.4 Imaging Methods for Detection 
Detection methods must include an imaging procedure along with a stimulus to induce 
vascular changes. There are several invasive and noninvasive methods to detect ED [7]. One 
example of an invasive imaging method would be X-Ray angiography, in which a radiopaque 
substance is injected into the bloodstream, which may not be desirable for a routine checkup.  
The nature of noninvasive imaging methods gives patients a practical option for routine 
testing to detect early symptoms, which could be a crucial factor for finding treatment. The 
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counter-argument for noninvasive methods would be their accuracy. Common noninvasive 
imaging methods for the detection of ED include ultrasound, MRI, and oscillometry. Although 
ultrasound and MRI are physically noninvasive, these methods present energy exposure to the 
body. Using oscillometry poses low risk for the individual because there is no energy exposure 
and it is the platform behind one method of blood pressure screening. Noninvasive imaging 
methods must be paired with a stimulus in order to get an effective reading of ED.  
1.5 Stimulus Methods 
A stimulus is used to inflict vascular changes within the body. One example of an invasive 
stimulus involves directly stimulating the artery by injection of substances into the blood stream 
that enhance the release of nitric oxide in the endothelium, such as acetylcholine or nitroglycerin 
[8]. However, invasive methods are high risk, and not suitable for asymptomatic patients. 
Noninvasive methods pose low risk for the individual and are therefore more desirable to 
administer regularly. An example of a noninvasive stimulus is reactive hyperemia. Reactive 
hyperemia is the body’s natural response of increased blood flow following arterial occlusion. 
During arterial occlusion, blood flow becomes blocked, and the local tissue’s oxygen supply 
depletes. When blood flow is released, the dilated blood vessels result in an increase in blood 
flow to resupply the local tissue with oxygen. This response is immediate and temporary, and 
blood flow returns to normal as the tissue’s oxygen supply levels out. There is low risk to this 
procedure and it is a simple method to induce vascular changes in the body. 
Reactive hyperemia will be described in this report by the duration that the arm cuff occludes 
blood flow. For example, 1 minute reactive hyperemia would be describing a test where the 
patient underwent cuff occlusion for 1 minute. The test will be abbreviated as 1 min RH. 
1.6 Arterial Occlusion as a Function of Blood Pressure 
Using an arm cuff, arterial occlusion occurs as a function of transmural pressure, which is the 
difference between the cuff pressure and the pressure felt inside the artery. Cuff pressure is 
increased by pumping air into the cuff and increasing its volume. To measure blood pressure, an 
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arm cuff is typically wrapped around an individual’s upper arm to measure the brachial artery 
pressure. The cuff is increased to a pressure that is high enough to induce a negative transmural 
pressure that causes the artery to occlude and block blood flow. The cuff pressure is then slowly 
released. The pressure at which the blood is able to resume blood flow is known as systolic blood 
pressure. Systolic blood pressure is defined as the pressure in the artery when the heart contracts. 
Its counterpart, diastolic blood pressure, is defined as the pressure in the artery when the heart is 
at rest between beats [9]. Systolic and diastolic pressures can be interpreted from Korotkoff 
sounds, known as the auscultatory method [10], or calculated using specified ratios of mean 
arterial pressure, known as the oscillometric method. Mean arterial pressure is the pressure at 
which cuff pressure and arterial pressure are equivalent.  
1.7 Current Standard 
The standard time of cuff occlusion to induce reactive hyperemia (RH) for assessing ED is 
currently 5 minutes. This standard is based on the 1995 study by Mary Corretti at the University 
of Maryland [11]. A method known as flow-mediated dilatation was performed, which uses high-
frequency ultrasound to measure the change in brachial artery diameter after inducing reactive 
hyperemia. In this test, 1, 3, and 5 min RH was tested. High-frequency ultrasound uses sound 
waves to produce real time cross-sectional images of the artery, shown in Figure 3. 
 
Figure 3 Ultrasound Image of Brachial Artery [12] 
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The percent change in artery diameter was calculated by dividing the increase in the 
dilated vessel diameter by the diameter at baseline. Seven individuals, (female n=3, male n=4) 
aged 29 to 38 years old (mean = 33 ± 3 years), with no known cardiovascular diseases underwent 
each of the 1, 3, and 5 min RH tests in a random order. To obtain the baseline value, each 
individual had their brachial artery diameter recorded for 1 minute intervals two times. Each 
individual had an arm cuff placed around the upper left arm and the operator inflated the cuff to 
200 mmHg for the specified duration of occlusion. Brachial artery diameter was imaged 
immediately after cuff deflation, and continued to be imaged for 20 minutes at 1 minute intervals. 
An operator blind to the study analyzed the images to obtain the measurements. A baseline test 
was done before each cuff occlusion test, and the order of the cuff occlusion durations was 
randomized. A 15 minute rest period was taken between each test. The reactive hyperemia test 
measurements were compared to their respective baseline measurements.  The results for this 
study are summarized in Table 2 and Figure 4.  
Table 2 Percent Change in Artery Diameter Following 1, 3, and 5 Min Cuff Occlusion [11] 
Duration 
of 
Occlusion 
(min) 
Immediate 
Release 
Minutes After Release 
1 3 5 10 15 20 
1 0.8 ± 6.9 2.1 ± 6.1 0.1 ± 5.2 0.3 ± 4.8 -0.1 ± 5.4 1.3 ± 5.3 -0.5 ± 3.1 
3 5.9 ± 11.5 7.8 ± 10.4 4.9 ± 8.0 0.8 ± 6.1 0.8 ± 5.2 -1.7 ± 4.0 -0.7 ± 3.2 
5 6.4 ± 4.9* 12.6 ± 5.7⌃ 8.0 ± 6.1⌃ 7.0 ± 4.9⌃ 4.4 ± 1.8⌃ 4.1 ± 3.7* 4.4 ± 4.3* 
* P < 0.05 vs. baseline; ⌃ P <0.01 vs. baseline 
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Figure 4 Percent Change in Diameter Following Release of 1, 3, and 5 Minutes of Cuff 
Occlusion [11] 
According to the results, with each increasing duration of cuff occlusion, the percent change 
in diameter increased. The 1 min RH test had the lowest mean percent increase of 0.57%, while 
the 3 min RH test had a mean percent increase of 2.54%, and the 5 min RH test had the highest 
mean percent increase of 6.7%. The 5 min RH test was the only test that produced significant 
differences from baseline, with a p-value of < 0.05. The results for the 5 min RH test remained 
significantly different from baseline throughout the 20 minutes after blood flow release. 
However, in the graph, significant overlap can be seen between the 5 and 3 min RH tests due to 
the high standard deviation of the 3 minute test. The standard deviation for the 3 min RH test is 
much higher than the other tests, which raises the thought that if the 3 min RH test had a lower 
standard deviation, would the results be able to show a significant difference from baseline. 
1.8 Flow-Mediated Dilatation 
Flow mediated dilatation (FMD) is a widely accepted method due to its noninvasiveness and 
effortlessness for the patient. The accepted standard cuff occlusion time for inducing reactive 
hyperemia in assessing ED is 5 minutes, based off the results to Mary Corretti’s study, as 
previously described [11, 13]. Although a widely accepted method, there is subjective error when 
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using FMD. The quality of the image is a critical parameter because the edge of the artery must 
be detected down to a single point. The subjective error associated with this method may arise 
from different operators with different judgments on the precise edge of the blood vessel, which 
highlights the importance of training. Critical parameters such as angle, alignment, and depth of 
the imaging system on the vessel must be kept consistent but are difficult to do so manually. If 
the alignment differs between tests, the diameter of the artery will be measured inaccurately [13]. 
This method requires the operator to have a high level of training in image analysis, which 
presents the possibility for a learning curve associated with this method. Lastly, FMD has only 
been shown to be optimal for arteries 2.5 – 5 mm in diameter [14]. This range limits which artery 
to measure, and singularizes the brachial artery as the best option for this test, due to over 90% of 
the population’s brachial artery being less than 5 mm. 
1.9 Oscillometric Techniques 
Oscillometric methods are widely accepted in blood pressure measurement, but have not been 
used as an ED detection method. An arm cuff is wrapped around an individual’s arm, which is 
inflated using a manual or automatic pump. Data collection software must be used in conjunction 
to measure the peak-to-peak (P-P) oscillations. By analyzing P-P cuff oscillations, less subjective 
error is present than in other methods because the software completes the measurements of the 
peaks objectively. However, there is a need to account for the variability due to the nonlinear 
pressure-volume sensitivity of the cuff, which increases with increased cuff pressure. The data 
analysis can be done immediately after completion of the test, allowing the patient to be able to 
get their results on the same day. Oscillometric methods estimate the arterial compliance by 
outputting a P-P oscillation amplitude measurement that represents how much the vessel changes 
in area with pressure. This is an accurate indicator of arterial compliance with a simple and 
precise analysis.  
The use of techniques using oscillometric methods could lead to results with lower standard 
deviations than FMD. The experimental goal of this study is to demonstrate a statistical 
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difference of mean P-P oscillations between the 3 min RH test with baseline. This statistical 
evidence would support the lowering of the standard cuff occlusion time from 5 minutes using 
FMD to 3 minutes using the oscillometric technique.  
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Chapter 2 
THEORY/LITERATURE REVIEW 
 
2.1 Endothelial Function and Dysfunction 
The human body consists of an extensive vascular network, which delivers blood and 
nutrients to every cell in the body. The vascular walls are made up of three distinct layers: tunica 
adventitia, tunica media, and tunica intima, as shown in Figure 5 [15]. The outermost layer is the 
tunica adventitia, which is a sturdy fibrous connective tissue that supports and holds the blood 
vessel together. The middle layer is the tunica media, which is composed of smooth muscle cells 
in series with collagen. The innermost layer is the tunica intima, or the endothelium, which is a 
single-celled layer with many functions. Its main function is to maintain vascular tone. In 
addition, the endothelium provides an anti-thrombotic inner lining to the vascular system and 
controls the passage of materials in and out of the bloodstream.  
 
Figure 5 Vascular Layers. Multiple layers of vascular walls: tunica externa, tunica media, and 
tunica intima. [15] 
As seen in Figure 6, endothelial cells respond to shear stress and maintain vascular tone 
by generating nitric oxide (NO) from L-arginine [16]. NO activates guanylate cyclase (sGC) in 
the smooth muscle cells of the tunica media. This causes smooth muscle cells to relax, causing 
the vessel diameter to widen, and thus causes vasodilation. NO also inhibits ET-1 synthesis. ET-1 
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is generated by endothelial cells and activates receptors Et-A and ET-B in smooth muscle cells, 
which causes the cells to constrict, narrowing the vessel diameter, and thus causes 
vasoconstriction. In summary, vascular tone is maintained by the ability of the endothelial cells to 
release smooth muscle cell vasodilator NO in response to high shear stresses.  
 
Figure 6 Proper Endothelial Cell Function Leads to Vasodilation and Vasoconstriction.  
L-Arg: L-Arginine, eNOS: endothelial nitric oxide synthase, NO: nitric oxide, ppET-1: 
preproendothelin-1, ET-1: endothelin-1, COX-1: cyclooxygenase-1, PGI2: prostacyclin, ETA: 
endothelin A, ETB: endothelin B, sGC: guanylate cyclase, cGMP: cyclic guanosine 
monophosphate. [16]  
When endothelial cells do not function properly, vascular diseases including 
atherosclerosis are at risk due to an increase in vasoconstriction. Cardiovascular disease risk 
factors include smoking, high cholesterol levels, and oxidative stress, which are mediators to ED 
[17]. Turbulent blood flow has also indicated to lead to ED due to studies showing that turbulent 
flow exhibited a very low shear stress on vascular walls and unsteady blood flow [18]. Steady, 
laminar blood flow causes a higher shear stress and has shown to induce cell alignment in the 
direction of flow, while unsteady flow and low turbulent shear stress induces cell loss and 
vasoconstriction. These events lead to regions in the vascular wall that are prone to 
atherosclerosis. In addition, pro-inflammatory cytokines and advanced glycation end-products 
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(AGE’s) are mediators to ED due to the activation of nuclear factor kappa-light-chain-enhancer 
of activated B cells (NF-κB). NF-κB is normally inhibited by NO synthesis. With a decrease in 
NO, there is an increase in endothelial activation, which leads to ED. In this context, endothelial 
activation is defined as an inhibition of NO secretion. As a result, the risk of vascular disease is 
increased.  
 
Figure 7 The Inhibition of NO Leads to Endothelial Dysfunction and Vascular Disease.  
AGE: Advanced glycation end products, NF-κB: nuclear factor kappa-light-chain-enhancer of 
activated B cells, VCAM-1: vascular cell adhesion molecule 1, ICAM-1: intercellular adhesion 
molecule 1, eNOS: endothelial nitric oxide synthase, NO: nitric oxide, SMC: smooth muscle cell, 
LDL: low-density lipoproteins, MMP: matrix metalloproteinase. [17] 
2.2 Reactive Hyperemia 
Reactive hyperemia is the immediate response of the body following arterial occlusion, 
including the dilation of blood vessels for the purpose of increasing blood flow and recovering 
from the loss of oxygen in tissues. Blood flow is closely correlated with tissue metabolic activity 
because oxygen, a necessary component in aerobic metabolism, is transferred to cells via the 
hemoglobin on red blood cells travelling through the blood stream [19]. During arterial occlusion, 
the oxygen supply from blood flow is cut off and local tissue hypoxia occurs downstream. 
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Hypoxia occurs when cells have a lower supply of oxygen than normal. Oxygen is needed in the 
mitochondria of cells during aerobic metabolism. Only in the presence of oxygen, do 
carbohydrates, amino acids, and fats work to convert adenosine-diphosphate (ADP) to adenosine-
triphosphate (ATP) for energy [20]. Along with tissue hypoxia, vasodilatory metabolites 
including adenosine, potassium ions, carbon dioxide, hydrogen ions, lactic acid, and inorganic 
phosphates are released, which results in the dilation of arterioles and causes a decrease in 
vascular resistance [19]. 
When arterial occlusion is released and blood flow reinitiates, the blood flow is increased due 
to both the dilation of blood vessels and a decrease in vascular resistance [21]. The longer the 
duration of occlusion, the stronger the response of increased blood flow is, as seen in Figure 8. 
Peak blood flow typically occurs within the first minute after release, but the response could last 
for several minutes depending on the site of occlusion. In the immediate blood flow response, the 
vasodilatory metabolites are cleared out of the local tissue as the tissue gets re-oxygenated. Since 
pressure returns to normal when blood flow gets released, vascular resistance increases while 
blood vessels gradually regain regular vascular tone.  Reactive hyperemia is the body’s survival 
mechanism to keep all cells alive. Because of the strong and immediate response, reactive 
hyperemia is a reliable mechanism in experimentation. 
 
Figure 8 Reactive Hyperemia Flow. Reactive hyperemia demonstrated by the amount of flow 
versus time and occlusion duration. [21] 
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2.3 Arterial Compliance 
Arterial compliance is the amount that an artery changes in area while changing in pressure 
[23]. When the cross-sectional area of an artery is graphed versus pressure, compliance is 
calculated as the derivative of this curve, shown in Figure 9, as the change in area over the change 
in transmural pressure. Transmural pressure is defined as the difference between the arterial 
pressure and cuff pressure. When transmural pressure is negative, the cuff pressure is higher than 
the arterial pressure; and when transmural pressure is positive, the cuff pressure is lower than the 
arterial pressure. At zero transmural pressure, the cuff pressure equals the mean arterial pressure. 
According to the graph, with data taken from 13 canine carotid arteries, it can be seen that the 
maximum slope in the area versus pressure curve, which represents the maximum compliance, 
occurs around zero transmural pressure.  
 
Figure 9 Arterial Properties vs. Transmural Pressure. (A) Lumen area (B) Compliance. [23] 
For large positive transmural pressures, the artery is able to retain its circular shape, and 
slight deviations in area are due to wall stretching by the action of smooth muscle cells and 
collagen in series in the media. The contractile component is the smooth muscle cell, while the 
collagen provides structural support. The smooth muscle cells in series with collagen represents 
the mechanical function of the artery, and is captured during the baseline test. Shown in Figure 11 
is a model of the structural layers of the artery. 
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When transmural pressure is near zero where compliance is high, the artery is no longer 
able to retain its shape, and its cross-section collapses to become an elliptical shape. This critical 
point is known as the buckling pressure. According to the Von Mises Buckling Theory [22], 
when the artery buckles, it is less capable at supporting external loads, which leads to geometric 
and elastic instability, and thus the largest changes in volume can be found here because changes 
in area are due to both wall bending and wall stretch [23].  The critical pressure can be described 
as: 𝑃𝑐𝑟𝑖𝑡 =  −𝐸ℎ
3 (𝑚
2−1)
[12𝑟3(1− 𝜇2)]
, where μ is Poisson’s ratio and equal to 0.5 for a blood vessel, m is 
the buckling mode and is equal to 2, and E is wall elasticity and equal to 
3𝜋𝑟3
2ℎ𝐶
. With the 
assumption that the cross-sectional area is circular, the radius equates to 𝑟 = (
𝐴
𝜋
)
1
2⁄
, where A is 
the lumen area, h is the wall thickness, and C is arterial compliance, based on Noordegraaf’s 
derivation [24]. The critical buckling pressure is not relevant when transmural pressure is below 
the critical buckling pressure, so the critical pressure is determined from Figure 10 where the 
dashed line, which is the equivalence of transmural pressure and critical buckling pressure, meets 
the solid line, which is the critical buckling pressure. According to Figure 10, the critical buckling 
pressure occurs near zero transmural pressure. 
 
Figure 10 Critical Buckling Pressure Computed for a Cylindrical Vessel [23] 
17 
 
When transmural pressure is below 0 mmHg, wall stretch is negligible, and changes in 
shape are due to wall bending from the recruitment of elastin and collagen in parallel in the 
intima [23, 25]. Smooth muscle cells are inhibited at this point. As the transmural pressure 
becomes increasingly negative, the artery collapses further until flat and blood flow is occluded. 
A cuff pressure of 50 mmHg greater than systolic pressure, or suprasystolic, is typically sufficient 
for the patient. The elastin in parallel with collagen represents the structural function of the artery 
and is captured during reactive hyperemia testing.  
 
Figure 11 Representative Model of Arterial Wall Components [26] 
2.4 Oscillometry 
Oscillometry relies on the theory that cuff oscillations directly correspond with arterial 
compliance, and that maximum cuff oscillations occur around zero transmural pressure, which is 
at mean arterial pressure (MAP). Several mathematical models of oscillometry were created to 
determine systolic and diastolic values using defined ratios of MAP. One example of the ratio for 
systolic and diastolic is 0.593 and 0.717, respectively [23]. Another example found was 0.55 and 
0.82 for systolic and diastolic, respectively [27]. These ratios were established by 
experimentation; however, no standardized ratio has been published. The discrepancy between 
the ratios helps explain the inaccuracy in blood pressure measurements. 
For blood pressure measurements, the oscillometric method utilizes an arm cuff and analyzes 
cuff oscillations to determine MAP and calculate systolic and diastolic values. The arm cuff is 
connected via an air tube to a release valve, pump, and pressure transducer. The cuff is typically 
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inflated to 20 – 30 mmHg above systolic (150 mmHg average) and deflated at a rate of 2 
mmHg/sec using the release valve [23]. A pressure versus time graph is high-pass filtered at 0.5 
Hz to reveal clearly the oscillations, typically of 1 – 5 mmHg, shown in Figure 12. The point of 
maximum oscillation corresponds with MAP and the desired corresponding ratios of MAP are 
taken to obtain systolic and diastolic values.  
 
Figure 12 Typical Oscillations in Cuff Pressure During a Blood Pressure Measurement by 
Oscillometry [23] 
The arterial waveform elicits a defined curve based on the mechanics of the blood flow, 
shown in Figure 13. The initial peak represents the opening of the aortic valve and left ventricular 
ejection into the aorta. This is the beginning of the systolic period. The pressure drops as it travels 
through peripheral vessels. When this pressure becomes lower than the aortic root pressure, the 
aortic valve closes, and the diastolic period begins. This event occurs at the dicrotic notch. The 
pressure continues to fall until it reaches its lowest point, known as end diastole. At this point, the 
left ventricle would refill with blood, contract, and repeat the cycle [28].  
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Figure 13 The Arterial Pulse Waveform [28] 
2.5 Cuff Mechanics 
In 1993, a group in the Department of Biomedical Engineering at Rutgers University worked 
to explain cuff mechanics [29]. Pressure-volume relationships were created through 
experimentation to come up with a widely accepted mathematical model for cuff mechanics. Two 
parameters were necessary to the model: cuff stretch, which was modeled by a nonlinear 
pressure-volume function, and air compression, which was represented by Boyle’s Law. A 
physical model was created for experimentation purposes.  
A glass cylinder 31 cm in circumference was used to represent a fixed-volume arm to allow 
cuff volume to be the only varying volume. An arm cuff was wrapped around the cylinder with a 
water-filled balloon placed between the cuff and the cylinder to represent the brachial artery, and 
two syringes filled with water and air were used to adjust the volume. A pressure transducer was 
used to measure pressure changes in the cuff. A schematic of the apparatus is shown in Figure 14.  
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Figure 14 Experimental Apparatus to Model Pressure Changes of a Blood Pressure Arm 
Cuff [29] 
The water inside the balloon was withdrawn until empty. Next, the air syringe injected air 
in increments of 10 mL while recording pressure and stopped when pressure reached 300 mmHg. 
Over the course of this experiment, the water syringe injected 5 mL of water in 1 mL increments, 
with the pressure being recorded for each 1 mL increment.  
 
Figure 15 Pressure vs. Volume. Pressure versus volume curves (left) and its derivative dP/dV 
(right). [29] 
A pressure versus air volume curve and its derivative, distensibility (dP/dV), were generated, 
showing the sensitivity of the cuff to the injected air volume. The graphs show that the pressure 
contained within the cuff is due to equilibrium between the compression of air and the stretch of 
the cuff. At high cuff pressures, the cuff sensitivity is increased, and a small change in pressure 
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yields a high volume change. The graph shows the cuff is volume sensitive up until about 150 
mmHg, to which it becomes constant. 
2.6 Oscillometric Model 
The article also discussed a mathematical model for the oscillometric method. Vi, the 
constant arm volume, is represented as 𝑉𝑖 = 𝑉𝑖𝑜 + 𝐴𝐿𝑐𝑢𝑓𝑓 , where A is the arterial lumen area, 
Lcuff is the length of the cuff, and Vio is the arm volume for the collapsed brachial artery. The 
elastic volume of the cuff, Ve, is subject to change and stretch. The difference between Ve and Vi 
represents the cuff volume, Vc. The cuff is initially at atmospheric pressure Pa, and contains an 
initial volume Vco. The total volume of air, Vp, is pumped into the cuff with pressure Pc. 
Following Boyle’s Law, 𝑃𝑉𝑐 = 𝑘, where k is a constant, the following equation applies: 
(𝑃𝑐 + 𝑃𝑎)𝑉𝑐 =  𝑃𝑎𝑉𝑐𝑜 + 𝑃𝑎𝑉𝑝. The cuff volume changes as the cuff is filled, and is linearly 
proportional to pressure changes at high pressures. The slope of this change represents the elastic 
stretch of the cuff. Maximum cuff elastance, Ec, is calculated by 𝐸𝑐 =  𝑃𝑐 [(
𝑉𝑒
𝑉𝑒𝑜
)
1
𝑛⁄
− 1]
𝑛
⁄ . Veo 
represents the volume of the cuff with zero stretch and n is a constant. The difference between Veo 
and Vco is the additional air found in the connector tube that is included in Vco.  
With n = 1, the cuff would function as a linear device. However, from experimentation, it is 
evident that the pressure-volume relationship is nonlinear, yielding a value for n that is greater 
than 1. The model was best fit to the experimental data to obtain values of each parameter, shown 
by the solid lines in Figure 15, and recorded in Table 3. The mathematical models for arterial 
compliance and the cuff are combined to determine a composite solution for cuff pressure with an 
arterial pressure pulse being the input to the model [23]: 
𝑃𝑎(𝑡) =  𝑀𝐴𝑃 + 𝐴0𝑠𝑖𝑛 (
2𝜋𝑓ℎ𝑟
60
) + 𝐴1sin (
4𝜋𝑓ℎ𝑟
60
+ 𝜙1) 
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Table 3 Constants to Composite Solution for Cuff Pressure [23] 
Name Quantity Value Units Role 
Atmospheric pressure Pa 760.0 mmHg 
Occlusive 
cuff constants 
Initial air volume in cuff and 
tubing 
Vco 1311.0 mL 
Zero stretch volume of cuff Veo 1316.9 mL 
Collapsed brachial artery arm 
volume 
Vio 1200.0 mL 
Constant of nonlinearity n 4.0836 N/A 
Maximum cuff elastance Ec 2.121 x 108 mmHg/mL 
Length of cuff Lcuff 13.0 cm 
 a 0.03 mmHg-1 
Brachial 
artery 
constants 
 b 3.30 N/A 
 c 0.10 mmHg-1 
 d 0.08 cm 
Mean arterial pressure MAP 95.0 mmHg 
Arterial 
pressure 
waveform 
constants 
 A0 10.0 mmHg 
 A1 9.0 mmHg 
 Φ1 1.2 radians 
Heart rate fhr 75 beats/min 
 
The complete oscillometry model was graphed, shown in Figure 16. Since the cuff 
pressure oscillations are small compared to cuff pressure, the data was high-pass filtered with a 
cut-off frequency of 0.5 Hz. The oscillations are shown along with the original curve in the left 
graph. The P-P oscillations were measured and displayed in the right graph. It can be seen that the 
maximum oscillation occurs at 95 mmHg, which would determine MAP for this case. Using 
MAP, systolic and diastolic ratios can be used to obtain systolic and diastolic pressures.  
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Figure 16 Oscillometry Model. Cuff pressure and oscillations in cuff pressure computed from 
the complete oscillometry model (left). P-P oscillations in cuff pressure obtained from left graph. 
Upper curve represents normalized oscillations and lower curve represents computed oscillations 
(right). [23] 
2.7 Error Mechanisms 
Techniques using the oscillometric method are widely used, so it is important to understand 
the error mechanisms of this method. It was found using a parametric sensitivity analysis of the 
model that the leading parameters that caused the highest error were the following [30]:  
• Systolic and diastolic errors were sensitive to the brachial artery stiffening around zero 
transmural pressure. 
• Systolic and diastolic values were overestimated and underestimated, respectively, when 
pulse pressure declined. 
Due to the high compliance of the artery around zero transmural pressure, there are high 
variations in compliance due to each heartbeat. This variation alters the amplitude of the 
oscillation that is sensed in the cuff. At zero transmural pressure, the pulse pressure, which is an 
indicator of how hard the heart is pumping, has a large effect on systolic and diastolic errors. In 
addition, limitations to the oscillometric method include not providing explicit systolic and 
diastolic pressures, but instead calculated values. It is important to understand the error 
mechanisms of the model when using oscillometry.   
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Chapter 3 
METHODS 
 
3.1 Experimental Methods 
This study obtained IRB Approval on April 13, 2018. Testing was done in a quiet classroom 
with temperature of 23°C over two consecutive days. Students volunteered to participate based 
off email and flyer advertisement around the campus. The Biopac MP160, HLT100C, and 
DA100C units, were connected to the laptop via USB with the pressure transducer and cuff 
connected to the Biopac DA100C unit. 
 
Figure 17 Schematic of Biopac Modules  
 
Figure 18 Biopac Equipment Setup. Biopac units connected to pressure transducer and arm 
cuff.  
The consent form was presented to each student before testing. The student’s name, age, 
and gender were recorded on a data sheet only viewable to the investigator. The student sat with 
their right arm facing palm up on a table. The Omron BP742 Automatic Blood Pressure Monitor 
was used to take the student’s blood pressure. The student was informed to keep feet flat on the 
HLT100C
Transducer 
module
DA100C
Differential 
bridge amplifier
Biopac MP160
Data acquisition
Computer
Analysis
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ground, sit still, and relax during the test. The student’s systolic and diastolic blood pressures 
were recorded. The purpose of this blood pressure measurement was to get the 50 mmHg above 
systolic value to occlude blood flow for the reactive hyperemia tests. The student then chose 
blindly from an envelope to determine which reactive hyperemia test would be performed first 
and proceeded with the baseline test. 
  
Figure 19 Baseline Test Setup. Omron unit measuring blood pressure on individual. Arm cuff 
placed on upper right arm with palm face up rested on table (left). Measurement of the arm cuff 
flap to ensure consistent tightness of arm cuff (right). 
For the baseline test, the Biopac arm cuff was wrapped around the individual’s upper 
right arm. To keep the tightness of the cuff consistent between the tests, the arm cuff flap was 
measured in centimeters with a ruler, shown in Figure 19, and documented on the data sheet. A 
marker was used on the student’s arm to mark the location of the cuff to keep the position of the 
cuff consistent as well between each test. The student was instructed to keep feet flat on the 
ground, sit still, and relax during the test. The pump was pumped to 50 mmHg suprasystolic and 
the investigator started recording data through the AcqKnowledge software. The pressure valve 
was released to slowly allow the arm cuff to deflate. Data recording was stopped when the cuff 
was fully deflated and cuff pressure reached about 0 mmHg.  
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Figure 20 Investigator Pumps Pressure to 50 mmHg Suprasystolic to Occlude Blood Flow 
For the reactive hyperemia tests, the student was instructed again to keep feet flat on the 
ground, sit still, and relax during the test. The pump was pumped to 50 mmHg suprasystolic and 
the investigator began recording the data through AcqKnowledge. A 3 or 5 minute timer was set 
and the pressure valve remained closed for this duration to hold pressure constant. When the 
specified time was complete, the pressure valve was released to slowly allow the cuff pressure to 
drop to the average MAP value of 100 mmHg, to which it was held constant for 30 seconds. After 
30 seconds, the pressure valve was released, allowing the cuff to deflate, and data collection 
ended.  
The student was instructed to return after a minimum of 30 minutes based on studies that 
show that 25 minutes is the minimum time for the body to return to normal physiological 
conditions for 90% of the population [32]. The arm cuff was placed within the markings 
identified on the student’s arm, and the arm cuff flap was measured to ensure the same tightness 
was kept between tests (± 0.5 cm). The second reactive hyperemia test was performed using the 
same method as previously described but with the other duration of occlusion. The entire method 
was repeated for each of the 20 students over a 2 day period of testing. All students returned for 
their second reactive hyperemia test on the same day of the first test. 
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3.2 Software Methods 
AcqKnowledge 4 Software was used to analyze the oscillometric waveforms obtained from 
the Biopac unit. AcqKnowledge was connected to Biopac by adding a new module for the 
DA100C Biopac unit using the TSD120 – Sphygmomanometer transducer. The following data 
acquisition settings were input into the software to create a new graph template. 
Table 4 Data Acquisition Settings for New Graph Template 
Sample rate 200 samples/second 
Acquisition Length 10 minutes 
 
A graph template was used for each student before their data collection, so each student 
had identical setup and settings. The template included a Journal and Measurements option. The 
journal allows the user to record measurements, images, and raw data. Measurements was 
selected to set up the specific measurements that were taken during data analysis. For this test, the 
selected channel (SC) was designated to measure Peak-to-Peak (P-P). P-P is the height of the 
oscillation from the lowest peak to the highest peak.  
 
Figure 21 Selected Channel Designated to Measure Peak-To-Peak (P-P) 
3.2.1 Baseline Test Analysis 
For each student, data collection began after the pressure was pumped to 50 mmHg 
suprasystolic. For the baseline test, data was collected until cuff pressure reached approximately 0 
mmHg. Shown in Figure 22 is an example of the baseline data. This file was saved with a unique 
code that kept the student anonymous. To obtain the arterial waveforms, a band pass filter with 
the parameters shown in Table 5 was implemented on the data. An example of the frequency 
response is shown in Figure 23. 
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Figure 22 Example of Baseline Data Before Filtering Using Acqknowledge 
Table 5 Band Pass Filter Parameters 
Source channel CH1, TSD120 – Sphygmomanometer, DA1000C 
Low Frequency cutoff (fixed) 0.5 Hz 
High Frequency cutoff (fixed) 5 Hz 
Number of Coefficients Optimize for sample rate and cutoff 
 
 
Figure 23 Frequency Response from Band Pass Filter on Baseline Data Using 
Acqknowledge 
The filtered response appeared in Channel 2. The shape of the filtered data reveals an 
increase in P-P oscillation height until a maximum peak was reached, and then a decrease in P-P 
oscillation height. This is the typical shape that is seen during blood pressure measurement tests.  
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Figure 24 AcqKnowledge Baseline Graph. Original baseline data (top) and filtered baseline 
data (bottom) using AcqKnowledge. 
The first waveform, which resembled the typical arterial waveform [28, 33], was 
selected, and the measurement was recorded to the journal. This process was repeated for each 
waveform that resembled an arterial waveform. The same process was repeated for each student’s 
baseline tests. 
 
Figure 25 Selection of P-P Measurements of Baseline Data Using Acqknowledge 
3.2.2 Reactive Hyperemia Tests Analysis 
For each student, data collection began after the pressure was pumped to 50 mmHg 
suprasystolic and continued through cuff pressure at 100 mmHg. Data collection ended after the 
30 second time window where cuff pressure was held at 100 mmHg following the 3 or 5 minutes 
of cuff occlusion at suprasystolic pressure. Figure 26 is an example of 3 min RH test data. The 3 
min and 5 min RH test data acquisitions were very similar to each other. The only difference 
between these two RH tests was the duration of cuff occlusion, while only the 30 second time 
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period post cuff occlusion where cuff pressure was held at 100 mmHg was used for data analysis. 
Similarly, to the baseline test, the P-P heights were measured and recorded to the journal.  
 
Figure 26 Original Data from a 3 Min Reactive Hyperemia Test Using Acqknowledge 
 
Figure 27 Selection of P-P Measurement for Reactive Hyperemia Data Using Acqknowledge 
3.3 Statistical Methods 
Peak-to-peak measurements were analyzed in JMP Pro 13 with a significance level of 
α=0.05. The P-P data was averaged for each student, and an ANOVA analysis determined the 
overall significance between the three test means: baseline, 3 min RH, and 5 min RH. For a 
further understanding of the data, the P-P data for each individual student was put into ANOVA 
to determine the statistical significance between the three test means individually. 
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Chapter 4 
RESULTS 
 
4.1 Student Mean Results 
Twenty Cal Poly students (female n=12, male n=8), aged 22 years old with a standard 
deviation of 2.04 years, underwent a baseline test, 3 min RH, and 5 min RH tests with sufficient 
rest in between. The P-P measurements for each student were averaged to obtain one value for 
each test and compared between all the students. For all tests, an alpha value of 0.05 was used to 
conclude any statistical significance. The results were summarized and shown below.  
Table 6 Peak-to-Peak Data for the Overall Means of the Students for Each Test 
Peak-to-Peak Data [mmHg] 
 
Test 
0 3 5 
N 20 20 20 
Mean 1.548 2.256 2.364 
Std Dev 0.506 0.441 0.529 
 
The Shapiro-Wilk Goodness-of-Fit Test tested the normality of the centered P-P data, 
which was generated using the residuals from the ANOVA analysis. The null hypothesis tested 
was that the data comes from a normal distribution. Evidence was found to conclude that the 
baseline test rejected normality, with a p-value of 0.0004, while the 3 and 5 min RH tests failed to 
reject normality, with p-values of 0.057 and 0.253, respectively.  
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Figure 28 Goodness of Fit Tests. Shapiro-Wilk Goodness of Fit Tests for the overall means of 
the students for each test. The baseline test rejected normality with a p-value of 0.0004. The 3 and 
5 minute tests failed to reject normality with p-values of 0.0572 and 0.2532. P-value must be less 
than 0.05 to be considered statistically significant.   
The variance between tests was tested using an Equal Variance test. Levene’s test was 
chosen to be most appropriate because it accounted for non-normal data. The null hypothesis 
tested was that the variances between the tests were equal. There was not enough evidence found 
to reject that the data has equal variance, with p-value of 0.607. The data suggests that the three 
tests had similar variances, so the student means presented a similar spread of data across all the 
tests.  
 
 
Figure 29 Equal Variance Tests. Levene’s equal variance test shows evidence that the means of 
the students for each test failed to reject equal variance with a p-value of 0.607. P-value must be 
less than 0.05 to be considered statistically significant. 
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A one-way ANOVA analysis compared the means between the three tests. The baseline 
test had the lowest mean at 1.5 mmHg, while the 3 and 5 min RH tests had similar means at 2.26 
mmHg and 2.36 mmHg, respectively. There is a high outlier in the baseline data. Further 
investigation into this student was done and explained in the Analysis.  
 
 
 
Figure 30 Overall ANOVA Results. ANOVA and Tukey Connecting Letters Report for the 
means of the students for each test show evidence that the baseline test is statistically lower than 
the 3 and 5 minute test means with a p-value less than 0.0001. P-value must be less than 0.05 to 
be considered statistically significant. 
The ANOVA showed a statistical difference for at least one test with a p-value less than 
0.0001. Tukey’s Connecting Letters Report revealed that the 3 and 5 min RH tests had similar 
means, and the baseline test had a significantly lower mean than the reactive hyperemia tests. 
Overall, the student mean data provided strong evidence that the mean P-P measurements from 
the 3 min RH test was significantly higher than the mean P-P measurements of baseline. 
4.2 Individual Results 
Although the previous analysis showed strong evidence of a significant difference between 
the 3 min RH test and baseline, it did not account for the variability within each student’s data, 
and thus, must be used in conjunction with an analysis on each individual student. The student 
means were expected to show differences due to several factors that could create differences in 
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the P-P oscillations including gender, age, diet, and stress. Due to this, each student was analyzed 
individually. For all tests, an alpha value of 0.05 was used to conclude any statistical significance. 
To assess normality, the Shapiro-Wilk Goodness of Fit Test was performed on the data for 
each test of each student for a total of 60 normality tests. The null hypothesis tested was that the 
data comes from a normal distribution. Analysis of these tests show that 42% of the tests failed to 
reject the normality test with p-values greater than 0.05, and 58% of the tests showed evidence 
which rejected the normality test, with p-values less than 0.05.  
Due to over half of the data showing non-normal distributions, Levene’s test was used to test 
equal variances. The null hypothesis tested was that the variances between the tests were equal. 
There were 18 of 20 students who rejected equal variances between the tests. For all of these 
students, the 3 and 5 min RH tests showed significantly lower variance than the baseline test. In 
addition, the 3 and 5 min RH tests showed to have similar variation to each other for every 
student. There were 2 students who failed to reject the equal variance test and showed similar 
variance between all tests, with p-values of 0.376 and 0.440. 
 
 
 
Figure 31 Standard Deviation ANOVA Results. ANOVA and Tukey Connecting Letters 
Report of the standard deviation of the students for each test show evidence that the baseline test 
standard deviation is statistically higher than the 3 and 5 minute test standard deviations with a p-
value less than 0.0001. P-value must be less than 0.05 to be considered statistically significant. 
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The variance was further analyzed by doing a one-way ANOVA and Tukey Connecting 
Letters Report to compare the mean standard deviations of the three tests for each student. It can 
be seen in the graph that the baseline had a larger spread of standard deviation, while the 3 and 5 
min RH tests had relatively consistent standard deviations between students. There was strong 
evidence with a p-value less than 0.0001 that the baseline test had a significantly higher mean 
standard deviation than 3 and 5 min RH tests. The baseline test had a mean standard deviation of 
0.603, while the 3 and 5 min RH tests had mean standard deviations of 0.247 and 0.254, 
respectively.  
The 20 students were analyzed individually with a one-way ANOVA to compare the 
means of the three tests: baseline, 3 min RH, and 5 min RH. The focus of the remainder of the 
results and analysis will be between baseline and 3 min RH to determine if there was enough 
evidence to support that the mean P-P measurements from 3 min RH was significantly higher 
than the mean P-P measurements at baseline for each student. The results are summarized below.  
Table 7 Individual Student Data for Peak-to-Peak Analysis 
1.  
 0 3 5 
N 21 42 38 
Mean 1.704 2.452 2.332 
Std Dev 1.199 0.253 0.255 
 
2.  
 0 3 5 
N 15 41 34 
Mean 1.783 1.968 1.956 
Std Dev 0.491 0.223 0.236 
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3.  
 0 3 5 
N 10 24 22 
Mean 1.549 1.786 1.747 
Std Dev 0.601 0.290 0.229 
 
4.  
 0 3 5 
N 8 40 35 
Mean 1.221 1.846 1.695 
Std Dev 0.367 0.201 0.205 
 
5.  
 0 3 5 
N 9 29 35 
Mean 1.823 2.704 2.938 
Std Dev 0.376 0.187 0.175 
 
6.  
 0 3 5 
N 8 24 40 
Mean 3.318 2.746 3.139 
Std Dev 1.011 0.343 0.422 
 
7.  
 0 3 5 
N 8 32 39 
Mean 1.249 2.684 3.423 
Std Dev 1.153 0.232 0.280 
 
8.  
 0 3 5 
N 39 40 48 
Mean 1.804 3.036 2.854 
Std Dev 0.774 0.458 0.290 
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9.  
 0 3 5 
N 23 33 38 
Mean 1.253 2.455 2.369 
Std Dev 0.553 0.384 0.328 
 
10.  
 0 3 5 
N 22 44 42 
Mean 1.607 2.743 2.441 
Std Dev 0.643 0.170 0.298 
 
11.  
 0 3 5 
N 14 49 42 
Mean 1.047 1.666 1.718 
Std Dev 0.426 0.197 0.194 
 
12.  
 0 3 5 
N 17 37 39 
Mean 1.340 1.694 2.269 
Std Dev 0.647 0.278 0.321 
 
13.  
 0 3 5 
N 6 37 40 
Mean 1.195 1.682 1.804 
Std Dev 0.334 0.235 0.244 
 
14.  
 0 3 5 
N 17 33 26 
Mean 1.651 2.427 2.523 
Std Dev 0.442 0.192 0.145 
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15.  
 0 3 5 
N 13 32 31 
Mean 1.640 2.517 2.953 
Std Dev 0.620 0.233 0.207 
 
16.  
 0 3 5 
N 15 39 46 
Mean 1.158 2.065 1.973 
Std Dev 0.424 0.164 0.189 
 
17.  
 0 3 5 
N 11 28 31 
Mean 2.010 2.664 2.849 
Std Dev 0.910 0.254 0.401 
 
18.  
 0 3 5 
N 9 39 39 
Mean 1.382 2.335 2.464 
Std Dev 0.346 0.207 0.197 
 
19.  
 0 3 5 
N 8 27 33 
Mean 1.224 1.757 1.673 
Std Dev 0.302 0.166 0.274 
 
20.  
 0 3 5 
N 8 42 42 
Mean 1.008 1.889 2.154 
Std Dev 0.435 0.274 0.188 
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There was strong evidence for 18 out of 20 students with at least one test showing a 
significant difference for mean P-P measurements with all tests having p-values less than 0.0001 
and one test with a p-value of 0.003, which is less than 0.05. Specifically, the goal was to show 
that 3 min RH had mean P-P measurements significantly higher than baseline. Seventeen of these 
18 students had strong evidence that 3 min RH was associated with significantly higher mean P-P 
measurements than baseline with p-values less than 0.0001 for each student.  
There was 1 student who had significantly lower mean P-P measurements for the 3 min 
RH test compared to baseline. The data showed that this student had several interruptions from 
motion artifact, resulting in data that may not be accurate. In addition, high outliers of the 
baseline test affected the baseline mean. There were also 2 out of 20 students who showed no 
significant differences between any of the tests. This was due to high standard deviations of the 
baseline test, which caused significant overlap into the other tests. These students had low mean 
P-P measurements for the 3 and 5 min RH tests and high standard deviation for all the tests. 
Overall from the individual student mean data, 17 of the 20 students showed strong evidence that 
the 3 minute test had significantly higher mean P-P measurements than baseline. 
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Chapter 5 
DISCUSSION 
 
5.1 Analysis 
The data was analyzed in two different ways to obtain valuable information from each 
analysis. The overall means for each student provided explicit evidence that the 3 min RH mean 
was statistically higher than the baseline mean. This analysis was done first to get an overall 
understanding of the data and to direct where further analysis was needed. However, due to a 
small sample size of 20 individuals, using 20 means does not provide high reliability in the data. 
The second analysis covered each student individually. This analysis provided a deeper analysis 
of the data and provided insight into the variance of each student. By measuring and analyzing 
each individual’s oscillation peaks, the number of data points increased from 60 total data points 
to 1733 total data points. However, this analysis did not provide concrete evidence of whether the 
3 min RH test was statistically significant from baseline due to varying results between students. 
There was no previously set acceptance criterion on how many students of the 20 had to show 
significant results in order to confirm the hypothesis. However, the best judgment was made 
based off the results. Fortunately, the two methods’ results were in agreement with each other. 
The combination of the two analyses validated the final conclusion: Overall, the analyses 
revealed strong evidence that 3 min RH was statistically higher than baseline with a p-value less 
than 0.0001.  
There were a few outliers found in the data. The baseline test had one high outlier. It was 
found through the individual data that this outlier might have been due to motion artifact. The 
student had three high peaks greater than 4 mmHg. Further investigation of this student also 
revealed that this was the one student whom the 3 min RH test mean was statistically lower than 
the baseline mean. The reason for this is the high variance of the baseline test, the high outliers, 
and a low number of baseline data points. The peaks in which motion artifact was evident were 
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not included in the data. This was decided based on the Channel 1 graph. If there were disruptions 
in the data, the respective peak was excluded from the study. For students with high amounts of 
motion artifact, the number of peaks was depleted. An example of an excluded peak is shown in 
Figure 32. Motion artifact caused enlarged peaks in the data. However, these peaks were not 
included in the final results.  
 
Figure 32 Example of Motion Artifact During Testing 
The overall mean data failed to reject the equal variance test, meaning that the baseline, 3 
min, and 5 min RH test means for the students were similar. This means that the students acted 
similarly between all the tests. Due to this, there is confidence that the method used was 
consistent between all the tests.  
The individual data provided less concrete, but insightful evidence to support the 
significant difference between 3 min RH and baseline. It was found through the equal variance 
test that the baseline test had higher variation than the 3 and 5 min RH tests for every student. The 
artery showed more variation in compliance compared to the 3 and 5 min RH tests because the 
baseline test measured the mechanical function of the artery, which is sensitive to the sympathetic 
behavior of the subject during the test. The 3 and 5 min RH tests remained at a fairly consistent 
size for the 30 second time collection period, as shown by the low variance in peaks for these 
tests. This steady response is expected for healthy endothelium because the RH tests are not 
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sensitive to the sympathetic behavior of the individual due to the structural integrity of the artery. 
The reactive hyperemia response is consistent within the 30 second window of data collection. As 
described in Corretti’s study, the 5 minute FMD test resulted in significantly higher oscillations 
even after 20 minutes of data collection at MAP. The 3 and 5 min RH tests had similar variation 
because these oscillations arise from the structural components of the artery wall. The expected 
response from a healthy individual would be consistent peaks in the reactive hyperemia tests.  
From Mary Corretti’s study, where the 5 minute standard originated [11,13], by using 
FMD techniques, it was found that the 3 min RH test’s standard deviation was very high and 
overlapped with baseline and the 5 min RH test, which disregarded it as significantly higher than 
baseline. Brachial artery ultrasound relies on the operator for the edge detection measurements, 
which could factor in human error to the variation. For this study using oscillometric techniques, 
the results showed a low standard deviation for 3 min RH, allowing 3 min RH to display its 
significance from baseline. The method used in this study poses less risk for human error in the 
measurements because the AcqKnowledge software measures and records the peaks.  
Two students showed that baseline, 3 min RH, and 5 min RH had no significant 
differences from each other. Further investigation into these two students showed that their 
baseline standard deviations were nearly double the standard deviation for the 3 and 5 minute 
tests, causing a large overlap. It did not appear that motion artifact caused the high deviation. 
These students had blood pressure on the lower side, especially the diastolic pressures. Holding 
the pressure at 100 mmHg to represent MAP may have been too high for these students which 
could help explain why these students did not show significant differences in the RH tests. If the 
pressure was held too high, the oscillations would not have given as strong as a response that 
would occur at MAP because blood flow would not have been fully released.  
The response of no significant differences between RH tests would be expected for 
diseased individuals. Since atherosclerosis causes plaque buildup and arteries to stiffen, arterial 
compliance would be low resulting in low P-P means for the RH tests. The standard deviation 
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would be high due to the weakened damaged endothelium not being able to elicit a consistent 
response. To explain this response from healthy individuals, this could have been a natural 
response from the students, the arm cuff may have been loose, or it could be due to experimental 
error. It would have been desired to test these individuals again, but due to unavailability of the 
students, this was not an option.   
From the results, the 3 and 5 min RH tests acted very similarly throughout the majority of 
the students. In addition to showing similarity, the tests also were found to be significantly higher 
than baseline for 17 out of 20 students. Five minutes of cuff occlusion using FMD is the current 
standard, but these results support the standard to be reduced to 3 minutes using oscillometric 
techniques to get more accurate results in a shorter testing period. General commentary from the 
students during and after testing were noted. There was a general consensus that the students 
preferred the 3 min RH test over the 5 min RH test due to slight discomfort felt during testing and 
the proximity of the 3 minute test in comparison to the 5 minute test. These reasons help to 
explain why reducing the cuff occlusion time is the ultimate goal to making the test more 
practical. 
It was critical to keep as many parameters as possible constant for each student and 
between each test in order to keep cuff compliance constant and to make relative comparisons. 
Cuff tightness was kept constant by measuring the arm flap, and arm location was kept constant 
by marking on the arm where to position the cuff. The same operator administered all the testing 
and environment was controlled because all testing was performed in the same classroom with 
minimal distractions. Also, the age range in which the students were chosen from was a tight age 
range because all the recruited individuals were college students with an age range of 18 – 27 
(mean = 22 years, standard deviation = 2.04 years). The goal was to include only healthy subjects 
in this study to decrease the possibility of high variability in the RH tests. Randomization of the 
order of the two RH tests was also important. For the second test, the individual knew what to 
expect, which could have resulted in less fidgeting, more calm nature, and less disturbances in 
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data collection. Keeping as many parameters constant and randomizing the run order eliminated 
these factors from contributing to any discrepancies of the results.  
One parameter that was difficult to control was motion artifact. Motion artifact was found 
in the AcqKnowledge graph results. Although instructed to remain still during the 30 second data 
collection period, it was present that students were displaying slight movements and fidgeting 
during testing. Motion artifact is a large factor to the discrepancies in the data because the cuff is 
very sensitive to movement.  
It was important to have a consent form that was understandable to the individual, as well as 
clear exclusion criteria on who would not be allowed to participate in the test. Students with 
known cardiovascular risk factors were not allowed to participate in the test, including but not 
limited to: hypertension, metabolic syndrome, atherosclerosis, peripheral artery disease, heart 
disease, cancer, asthma, obesity, diabetes, etc. It was critical that all the participants were healthy 
in order to get significant results and avoid diseased arteries to cause discrepancies in the data. 
5.2 Limitations 
There were several limitations that presented themselves during this test. The small sample 
size was one limitation. Testing was performed during Final’s Week of Spring Quarter 2018. Due 
to a restricted amount of time, it was more difficult to find a high number of willing students 
during this time of the school year.  
A second limitation was that the operator was not a professionally trained medical operator, 
which is preferred for this test. However, the operator did have previous experience using blood 
pressure measurement devices and had an adequate amount of time to self-train on the software 
program. Since it was up to the operator to determine which arterial waveforms fit the typical 
arterial waveform curve, and which ones shouldn’t be included in the measurements, subjective 
error may have been presented here in the determination of which peaks were included in the 
analysis. A small percentage of peaks for the baseline test had to be eliminated due to motion 
artifact, resulting in a lower number of peaks. When cuff pressure reached around 50 mmHg, the 
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peaks decreased in size and appeared to lose the arterial waveform curve and therefore were not 
measured. These low-end peaks were not included in the results because the cuff becomes loose 
at low pressures and is unable to detect the arterial waveforms. The low number of peaks 
contributed to the high variation for the baseline test compared to the RH tests.  
The AcqKnowledge program had a 0.001 resolution for measuring peaks. There were several 
duplicate measurement values for various peaks and it was believed this had an impact on the 
normality distribution being rejected for 58% of the tests. Although this resolution provided 
accurate data for the purposes of this study, a higher resolution would have allowed for a normal 
distribution of the data. 
The last limitation was that the MAP was kept at 100 mmHg for each student. This MAP was 
used as an average. However, the true MAP for each student may have been slightly different 
from 100 mmHg, which would have affected the P-P oscillations. 
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Chapter 6 
CONCLUSIONS 
 
The purpose of this test was to test whether the use of the oscillometric technique would 
lead to significant results from baseline for 3 minute reactive hyperemia versus the standard of 5 
minute reactive hyperemia. Peak-to-peak oscillations were compared between the three tests: 
baseline, 3 minute reactive hyperemia, and 5 minute reactive hyperemia. Overall, there was 
strong evidence to support that the use of the oscillometric technique led to significant findings 
between the 3 minute reactive hyperemia test and baseline with p-values less that 0.05. From 
these results, strong evidence was obtained to support the lowering of the standard cuff occlusion 
time from 5 minutes using FMD to 3 minutes using the oscillometric technique described in this 
study.  
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Chapter 7 
FUTURE INNOVATIONS 
 
7.1 Improvements to Study 
Several ideas and future improvements arose while performing this study. It would have been 
beneficial to further stress the importance to keep movements to a minimum. Although advised to 
remain still during testing, the investigator noticed small movements in the individuals. Minor 
movements caused peaks to be excluded from the study, so the importance of keeping completely 
still should be stressed in the future. An alternative would be a strap that connects to the table to 
aid in the individual to remain still. Also, further restrictions on the individual could be helpful 
for more accurate data. A suggestion would be to inflict dietary and exercise restrictions on the 
individuals for a set amount of time before testing or in between testing. For example, a 
restriction of no caffeine or intense exercise done 12 hours prior to testing would allow 
individuals to come in relaxed with a resting pulse rate, which would help in the consistency of 
the oscillation heights throughout all testing.  
The investigator labeled each file with a specific code to link to which student, what test, and 
what the order of the tests were. Although anonymous to others, the investigator was aware of 
which peaks were from the 3 minute or 5 min RH test. For future improvements, it would be 
desired for the measurement taker to be blind to which test he or she is measuring so that there 
could be no possibilities of bias input into the results. However, for this test the AcqKnowledge 
program measured the peaks, so there was low risk of bias in these results. 
Data collection for the 3 and 5 min RH tests began when the pressure was 50 mmHg above 
the individual’s systolic value, and continued for the duration of the 3 and 5 minutes in addition 
to the 30 second reactive hyperemia period. However, the data during the 3 and 5 minutes of cuff 
occlusion were not looked at during data analysis. For future studies, the data collection may 
begin after the 3 and 5 minutes, right before the pressure is reduced to 100 mmHg, or MAP. This 
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would allow for only the necessary data to be included in the saved file. Also, instead of using an 
average MAP of 100 mmHg, future studies should use the MAP that is specific to each patient. 
This information can be obtained during the blood pressure or baseline test, and would only 
require a slight delay between the baseline test and the reactive hyperemia tests to obtain the 
specific MAP value.  
Another future study would be to experiment with keeping other pressures constant. For 
instance, if pressure was held at diastolic pressure, the test results have the potential to show a 
more accurate reading for those with lower blood pressure values. The test may show lower cuff 
compliance and lower differences between diseased and healthy endothelium, but has the 
potential to have a stronger reactive hyperemia response due to increased blood flow. The 
advantages and disadvantages of holding pressure constant at other pressures would be a valuable 
future study.  
Age and gender were recorded for each student, but further traits that could be helpful for 
future analyses would be height, weight, BMI, exercise routine, smoker status, and diet. This 
would be beneficial information to have for future studies because although all the subjects in this 
study were healthy individuals with no known cardiovascular risk factors, it would be valuable 
information to trend due to some people who may be unaware of their risk for cardiovascular 
disease. In 2013, it was found that 64% of women who died of coronary heart disease were 
asymptomatic [34]. The investigator may also be able to make the judgment from the patient’s 
cardiovascular health based on the cardiovascular health metrics.  
7.2 Next Steps 
Although these results gave strong evidence that the 3 min RH test mean is statistically higher 
than the baseline mean, future studies would need to be done to further validate the claim to lower 
the standard from 5 minutes using FMD to 3 minutes using the oscillometric technique. Future 
studies would include expanding the sample size to allow for increased reliability and confidence 
in the results. In addition, the study should be done on the same individual more than once to gain 
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repeatability in the results. For example, the same individual could repeat the test every 3 months 
for a year or more. Another necessary future study would be to include both individuals who are 
at risk of cardiovascular disease in the study as well as healthy individuals. Gathering the 
information on certain known risk factors to cardiovascular disease and their correlation with P-P 
measurements would allow for a better understanding into the traits and their effect on the test. 
Extensive testing must be done before this method can be used as a diagnosis tool, but including 
at risk individuals in future studies would allow for valuable information to determine if the test is 
sensitive enough to distinguish diseased arteries from healthy arteries. 
7.3 Benefits of Pushing this Test Forward 
There are several benefits to pushing this test forward and proceeding with the future tests as 
previously described. Eventually the goal for this test would be to use at routine hospital 
checkups for all adult patients: those who have known cardiovascular risk factors and those who 
do not. Since the test is noninvasive, there would be no complications to administering this test at 
routine checkups. Due to its similarity to routine blood pressure measurement tests, the test could 
be taken right after blood pressure is taken, and would only require 3 additional minutes to get 
potentially critical life-saving information. 
The hospitals would have professionally trained operators to analyze the data and return 
results to the patient within hours or even minutes of testing. This test would be able to determine 
the presence of early indicators of cardiovascular disease at the earliest stage before harmful 
effects occur to the patient. At this point, the doctor would be able to recommend to the patient 
certain lifestyle changes that could prevent the disease from progressing before it even got 
started. The doctor could also provide medication for the individual if necessary, and the 
treatment has the potential to be more effective due to the early treatment in relation to the 
progression of the disease. 
By reducing the duration of the test, the patient’s stay in the hospital gets reduced, which 
would also reduce hospital costs. The benefits of this test are unmatched because it provides 
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people with a tool to determine if they are at risk for cardiovascular disease, before it is too late 
when treatment may not be an option. This test has the potential to have a global impact and save 
patient’s lives around this world in which cardiovascular disease is the leading cause of death. 
The future to saving patients’ lives relies on early diagnosis, so this test would be a significant 
step in this direction because it allows for a quick noninvasive method for early detection of 
cardiovascular diseases. 
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Student 1: 0612BJ 
Peak-to-Peak Data Graph 
Baseline 3 Minute 5 Minute Baseline 
 
Baseline Frequency Response 
 
 
0612BJB 0612BJ3M1 0612BJ5M2 
0.787 
1.236 
0.928 
1.274 
1.009 
4.703 
3.356 
2.206 
1.391 
3.444 
4.007 
1.514 
2.315 
1.836 
1.090 
1.023 
0.702 
0.914 
0.700 
0.775 
0.576 
 
3.204 
2.441 
2.441 
2.288 
1.678 
2.288 
1.983 
2.593 
2.593 
2.288 
2.593 
2.288 
2.288 
2.593 
2.288 
2.746 
2.136 
2.288 
2.288 
2.593 
2.441 
2.593 
2.746 
2.593 
2.136 
2.441 
2.288 
2.593 
2.441 
2.746 
2.593 
2.288 
2.593 
2.593 
2.593 
2.136 
2.593 
2.288 
2.441 
2.593 
2.746 
2.593 
2.441 
2.288 
1.983 
2.288 
2.288 
2.288 
2.441 
2.136 
2.136 
2.288 
1.983 
2.288 
2.136 
2.136 
2.288 
2.441 
2.441 
2.593 
2.288 
2.593 
2.899 
3.051 
2.288 
2.746 
2.441 
2.288 
2.136 
2.136 
1.831 
1.831 
2.136 
2.288 
2.593 
2.593 
2.288 
2.441 
2.441 
2.441 
 
3 Minute 
 
 
5 Minute 
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Student 2: 0612BK 
Peak-to-Peak Data Graph 
Baseline 3 Minute 5 Minute Baseline 
 
Baseline Frequency Response 
 
 
0612BKB 0612BK3M1 0612BK5M2 
0.998 
1.334 
1.437 
1.859 
2.246 
2.229 
2.187 
2.445 
2.481 
2.263 
1.699 
1.466 
1.533 
1.391 
1.174 
 
2.441 
1.983 
1.831 
2.136 
1.983 
1.831 
1.983 
1.831 
2.136 
2.136 
2.136 
2.136 
1.831 
2.136 
2.288 
1.983 
1.983 
1.831 
1.983 
2.136 
1.983 
1.983 
1.983 
1.983 
2.136 
1.831 
1.831 
2.288 
1.983 
1.983 
2.136 
1.983 
1.983 
1.678 
1.678 
1.373 
1.373 
1.525 
2.288 
1.983 
1.983 
 
2.288 
2.136 
1.678 
2.136 
1.983 
2.288 
2.136 
1.525 
1.525 
1.525 
1.831 
1.831 
1.678 
1.983 
1.678 
1.831 
1.678 
1.983 
1.831 
1.983 
2.136 
1.831 
2.136 
2.136 
2.136 
1.983 
2.136 
1.831 
1.678 
2.136 
2.136 
2.136 
2.288 
2.288 
 3 Minute 
 
 
5 Minute 
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Student 3: 0612BP 
Peak-to-Peak Data Graph 
Baseline 3 Minute 5 Minute Baseline 
 
Baseline Frequency Response 
 
 
0612BPB 0612BP3M2 0612BP5M1 
1.229 
1.624 
2.010 
2.088 
1.964 
2.346 
1.837 
0.775 
0.984 
0.637 
 
1.678 
1.373 
1.373 
1.678 
1.831 
1.678 
1.678 
1.831 
2.136 
2.593 
1.983 
1.831 
1.678 
1.983 
1.525 
1.831 
1.678 
1.831 
1.831 
1.525 
1.220 
1.983 
1.983 
2.136 
 
1.983 
1.831 
1.525 
1.678 
1.525 
1.678 
1.983 
1.678 
1.831 
1.983 
1.678 
1.525 
1.525 
1.831 
2.136 
1.831 
1.678 
1.525 
2.288 
1.831 
1.525 
1.373 
 
3 Minute 
 
 
5 Minute 
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Student 4: 0612EK 
Peak-to-Peak Data Graph 
Baseline 3 Minute 5 Minute Baseline 
 
Baseline Frequency Response 
 
 
0612EKB 0612EK3M2 0612EK5M1 
1.111 
1.328 
1.419 
1.570 
1.368 
1.240 
0.931 
0.667 
0.574 
0.384 
0.571 
0.450 
 
1.831 
1.373 
1.678 
1.983 
1.678 
1.525 
1.678 
1.831 
1.525 
1.983 
1.831 
2.136 
2.288 
1.983 
1.983 
1.983 
2.288 
1.831 
1.678 
1.678 
1.831 
1.678 
2.288 
1.831 
1.831 
1.831 
1.831 
2.136 
1.983 
1.678 
1.831 
1.831 
1.831 
1.831 
1.678 
1.831 
1.831 
1.678 
1.831 
1.983 
 
1.831 
1.678 
1.983 
1.525 
1.525 
1.678 
1.373 
1.525 
1.373 
1.678 
1.678 
1.678 
1.525 
1.525 
1.678 
1.525 
1.525 
1.525 
1.525 
2.136 
1.831 
1.525 
1.678 
1.678 
1.678 
1.373 
1.678 
1.831 
1.983 
1.831 
2.136 
1.983 
1.983 
1.831 
1.831 
 
 
3 Minute 
 
 
5 Minute 
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Student 5: 0612GL 
Peak-to-Peak Data Graph 
Baseline 3 Minute 5 Minute Baseline 
 
Baseline Frequency Response 
 
0612GLB 0612GL3M2 0612GL5M1 
1.448 
1.873 
2.206 
2.308 
2.218 
1.771 
1.641 
1.181 
1.757 
 
2.288 
2.746 
2.746 
2.593 
2.746 
2.441 
2.593 
2.746 
2.288 
2.441 
2.746 
2.441 
2.746 
2.746 
2.746 
2.746 
2.899 
2.899 
2.899 
2.746 
2.899 
2.746 
2.746 
2.899 
2.899 
2.593 
2.593 
2.746 
3.051 
 
2.899 
2.746 
3.051 
3.051 
3.051 
2.899 
2.746 
2.899 
3.204 
3.051 
2.746 
3.051 
3.051 
2.899 
3.051 
2.593 
2.593 
2.746 
2.899 
3.204 
3.051 
3.051 
3.051 
2.899 
2.899 
2.593 
3.051 
3.204 
3.051 
2.593 
3.051 
3.051 
3.051 
2.899 
2.899 
 
3 Minute 
 
 
5 Minute 
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Student 6: 0612JF 
Peak-to-Peak Data Graph 
Baseline 3 Minute 5 Minute Baseline 
 
Baseline Frequency Response 
 
0612JFB 0612JF3M1 0612JF5M2 
3.051 
3.204 
2.136 
1.831 
4.577 
4.425 
4.119 
3.204 
 
2.593 
2.746 
2.288 
2.441 
2.899 
3.051 
2.593 
3.509 
2.288 
2.593 
2.288 
2.746 
2.593 
2.746 
2.441 
3.051 
3.204 
2.288 
2.899 
2.593 
2.593 
3.051 
3.204 
3.204 
 
3.051 
2.441 
2.746 
3.204 
3.356 
3.204 
3.051 
2.593 
3.814 
2.746 
2.593 
3.356 
3.814 
3.356 
3.814 
3.204 
2.746 
2.441 
2.441 
2.746 
2.746 
2.899 
2.593 
3.204 
3.509 
3.356 
3.662 
3.509 
3.509 
3.509 
3.662 
3.051 
2.746 
2.899 
2.899 
2.899 
3.356 
3.662 
3.509 
3.662 
 
3 Minute 
 
 
5 Minute 
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Student 7: 0612JK 
Peak-to-Peak Data Graph 
Baseline 3 Minute 5 Minute Baseline 
 
Baseline Frequency Response 
 
0612JKB 0612JK3M2 0612JK5M1 
3.207 
2.849 
1.435 
0.716 
0.538 
0.454 
0.385 
0.405 
 
2.593 
2.288 
2.746 
3.051 
2.136 
2.288 
2.441 
2.899 
2.746 
3.051 
2.899 
2.593 
2.746 
2.746 
2.593 
2.746 
2.899 
2.593 
2.899 
3.051 
3.051 
2.593 
2.593 
2.899 
2.746 
2.441 
2.593 
2.593 
2.593 
2.593 
2.746 
2.441 
 
3.356 
3.509 
3.204 
3.509 
3.662 
3.356 
3.814 
3.509 
3.814 
3.509 
3.814 
3.356 
3.509 
3.509 
3.509 
3.662 
3.509 
3.509 
3.509 
3.356 
3.509 
3.051 
3.204 
3.814 
3.509 
3.967 
2.899 
2.899 
2.899 
3.662 
3.509 
3.051 
3.204 
2.899 
3.051 
3.204 
3.509 
3.662 
3.509 
 
3 Minute 
 
5 Minute 
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Student 8: 0612JL 
Peak-to-Peak Data Graph 
Baseline 3 Minute 5 Minute Baseline 
 
Baseline Frequency Response 
 
 
0612JLB 0612JL3M2 0612JL5M1 
0.777 
1.413 
1.956 
2.167 
1.941 
2.199 
2.365 
2.170 
2.250 
2.707 
2.967 
2.743 
2.952 
3.023 
2.867 
3.446 
3.107 
2.742 
2.214 
1.538 
1.425 
1.074 
1.298 
1.415 
1.461 
1.270 
1.429 
1.508 
1.534 
1.469 
1.061 
1.037 
0.820 
1.086 
1.221 
1.206 
0.970 
0.782 
0.754 
 
 
2.746 
2.136 
1.678 
2.441 
2.746 
2.899 
3.356 
3.356 
3.204 
3.356 
3.204 
3.509 
3.509 
3.356 
3.051 
2.593 
2.899 
2.899 
3.204 
3.204 
3.356 
3.356 
3.051 
2.899 
2.441 
2.288 
2.593 
2.441 
3.204 
3.204 
2.899 
3.051 
3.356 
3.814 
3.509 
3.509 
3.662 
3.662 
3.051 
2.746 
 
 
3.204 
3.204 
2.746 
2.899 
2.746 
2.593 
2.899 
2.899 
2.899 
2.746 
3.051 
2.899 
3.204 
2.899 
2.288 
2.746 
2.593 
2.593 
2.593 
2.899 
3.356 
2.746 
2.746 
3.051 
2.899 
3.051 
2.899 
3.051 
3.204 
2.899 
3.051 
3.204 
3.051 
2.899 
2.593 
3.051 
3.204 
2.899 
2.899 
2.899 
3.204 
3.051 
2.746 
2.899 
2.441 
2.288 
2.136 
1.983 
 
3 Minute 
 
5 Minute 
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Student 9: 0612KV 
Peak-to-Peak Data Graph 
Baseline 3 Minute 5 Minute Baseline 
 
Baseline Frequency Response 
 
 
0612KVB 0612KV3M2 0612KV5M1 
1.537 
1.676 
1.862 
1.744 
2.164 
2.096 
2.130 
1.885 
1.490 
1.602 
1.150 
1.202 
1.061 
0.927 
0.730 
0.877 
0.678 
0.732 
0.786 
0.638 
0.660 
0.604 
0.597 
 
 
2.441 
2.593 
2.746 
1.983 
2.441 
1.983 
1.678 
1.678 
1.678 
2.136 
2.593 
2.899 
2.746 
2.746 
2.593 
2.899 
2.899 
2.746 
2.899 
2.593 
2.288 
2.288 
2.288 
1.678 
2.288 
2.441 
2.746 
2.746 
2.746 
2.746 
2.746 
2.441 
2.593 
 
 
3.051 
2.593 
2.288 
2.899 
2.136 
2.288 
3.051 
2.746 
2.441 
1.678 
3.356 
1.983 
2.441 
2.441 
2.288 
1.983 
2.288 
2.288 
2.136 
2.136 
2.288 
2.288 
2.136 
2.136 
2.441 
2.136 
2.288 
2.136 
2.288 
2.593 
2.288 
2.746 
2.288 
2.288 
2.441 
2.441 
1.983 
2.288 
 
 
3 Minute 
 
5 Minute 
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Student 10: 0612NB 
Peak-to-Peak Data Graph 
Baseline 3 Minute 5 Minute Baseline 
 
Baseline Frequency Response 
 
 
0612NBB 0612NB3M1 0612NB5M2 
3.391 
2.089 
2.243 
2.314 
2.306 
2.109 
2.074 
1.779 
1.704 
1.546 
1.543 
1.400 
1.575 
1.411 
1.045 
1.207 
1.035 
0.879 
1.134 
0.913 
0.901 
0.755 
 
2.746 
2.746 
2.441 
2.593 
2.441 
2.593 
2.593 
3.051 
2.746 
2.899 
2.899 
2.899 
2.746 
2.746 
2.899 
2.288 
2.593 
2.746 
2.899 
2.899 
2.899 
2.441 
2.746 
2.899 
2.593 
2.899 
2.899 
2.746 
2.746 
2.593 
2.746 
2.746 
2.746 
2.441 
2.746 
2.593 
2.746 
2.899 
2.899 
2.746 
2.899 
2.746 
2.746 
3.051 
 
3.051 
2.288 
2.593 
1.983 
1.373 
1.983 
2.899 
2.441 
2.593 
2.441 
2.441 
2.441 
1.983 
2.593 
2.441 
2.441 
2.288 
2.746 
2.593 
2.593 
2.746 
2.441 
2.593 
2.746 
2.288 
2.441 
2.288 
2.441 
2.746 
2.441 
2.593 
2.136 
2.441 
2.288 
2.593 
2.441 
2.288 
2.593 
2.593 
2.899 
1.983 
2.288 
 
 
 
 
 
 
 
 
 
 
 
 
3 Minute 
 
5 Minute 
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Student 11: 0612PF 
Peak-to-Peak Data Graph 
Baseline 3 Minute 5 Minute Baseline 
 
Baseline Frequency Response 
 
 
0612PFB 0612PF3M1 0612PF5M2 
1.091 
1.089 
1.208 
1.435 
1.859 
1.677 
1.306 
1.053 
0.931 
0.776 
0.570 
0.602 
0.536 
0.520 
 
1.525 
1.373 
1.525 
1.525 
1.525 
1.831 
1.831 
1.831 
1.525 
1.525 
1.525 
1.831 
1.831 
1.678 
1.983 
1.983 
1.678 
1.373 
1.373 
1.831 
1.525 
1.525 
1.525 
1.678 
1.678 
1.373 
1.678 
1.678 
1.831 
1.831 
1.983 
1.831 
1.525 
1.831 
1.525 
1.373 
1.525 
1.831 
1.831 
2.136 
1.831 
1.983 
1.525 
1.525 
1.525 
1.525 
1.373 
1.831 
1.678 
 
1.678 
1.525 
1.678 
1.525 
1.678 
1.678 
1.678 
1.831 
1.525 
1.525 
1.525 
1.678 
1.525 
1.678 
1.678 
1.525 
1.983 
1.831 
2.136 
1.678 
1.983 
1.831 
1.525 
1.525 
1.678 
1.678 
1.983 
1.373 
2.136 
1.831 
1.678 
1.983 
1.678 
1.983 
1.983 
1.678 
1.678 
1.983 
1.678 
1.373 
1.525 
1.831 
 
 
3 Minute 
 
 
5 Minute 
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Student 12: 0612RK 
Peak-to-Peak Data Graph 
Baseline 3 Minute 5 Minute Baseline 
 
Baseline Frequency Response 
 
 
0612RKB 0612RK3M1 0612RK5M2 
1.000 
1.306 
1.561 
1.800 
1.811 
2.258 
2.506 
2.295 
1.499 
1.552 
1.228 
0.946 
0.708 
0.662 
0.473 
0.563 
0.615 
 
1.678 
1.220 
1.678 
1.678 
1.373 
1.983 
1.678 
1.678 
2.136 
1.678 
1.678 
1.525 
1.525 
1.983 
1.525 
1.525 
1.373 
1.678 
1.220 
1.373 
1.678 
1.525 
1.678 
1.983 
2.136 
1.678 
1.373 
1.525 
1.525 
1.525 
1.831 
1.983 
1.678 
1.678 
2.136 
2.441 
2.136 
 
2.899 
2.593 
2.593 
1.525 
1.831 
2.288 
2.288 
2.136 
1.983 
1.678 
2.136 
1.678 
2.288 
2.593 
2.593 
2.593 
2.288 
1.983 
1.831 
1.983 
2.136 
2.288 
2.288 
2.441 
1.983 
2.136 
2.441 
2.136 
2.441 
2.441 
2.593 
2.136 
2.136 
2.136 
2.593 
2.746 
2.593 
2.746 
2.288 
 3 Minute 
 
 
5 Minute 
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Student 13: 0612SS 
Peak-to-Peak Data Graph 
Baseline 3 Minute 5 Minute Baseline 
 
Baseline Frequency Response 
 
 
0612SSB 0612SS3M2 0612SS5M1 
1.017 
0.908 
1.211 
1.629 
1.560 
0.847 
 
1.831 
1.831 
1.831 
1.678 
1.373 
1.525 
1.373 
1.983 
2.136 
1.831 
1.678 
1.831 
1.678 
2.288 
1.831 
1.678 
1.220 
1.373 
1.525 
1.525 
1.831 
1.678 
1.831 
1.525 
1.983 
1.983 
1.678 
1.678 
1.831 
1.525 
1.525 
1.525 
1.373 
1.525 
1.525 
1.831 
1.373 
 
2.136 
1.678 
2.136 
1.831 
1.831 
1.678 
1.983 
1.525 
1.983 
1.220 
1.525 
1.831 
1.678 
1.831 
1.831 
1.678 
1.525 
1.831 
1.831 
1.831 
1.983 
1.525 
1.831 
1.983 
1.831 
1.678 
1.983 
1.678 
1.678 
1.525 
1.525 
1.525 
1.678 
1.831 
2.288 
1.831 
1.983 
1.831 
2.593 
1.983 
 
3 Minute 
 
 
5 Minute 
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Student 14: 0613JL 
Peak-to-Peak Data Graph 
Baseline 3 Minute 5 Minute Baseline 
 
Baseline Frequency Response 
 
 
0613JLB 0613JL3M2 0613JL5M1 
0.937 
1.313 
1.625 
1.879 
1.948 
2.025 
1.945 
1.958 
2.048 
2.049 
2.152 
2.040 
1.707 
1.413 
1.137 
0.969 
0.917 
 
2.746 
2.441 
2.288 
2.746 
2.899 
2.136 
2.136 
2.441 
2.136 
2.288 
2.288 
2.288 
2.593 
2.136 
2.441 
2.441 
2.441 
2.441 
2.288 
2.288 
2.441 
2.746 
2.441 
2.441 
2.593 
2.593 
2.441 
2.593 
2.441 
2.441 
2.136 
2.441 
2.441 
 
2.593 
2.441 
2.441 
2.288 
2.441 
2.593 
2.441 
2.899 
2.593 
2.441 
2.593 
2.441 
2.441 
2.746 
2.441 
2.441 
2.441 
2.441 
2.441 
2.593 
2.899 
2.593 
2.593 
2.441 
2.441 
2.441 
 
3 Minute 
 
 
5 Minute 
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Student 15: 0613JS 
Peak-to-Peak Data Graph 
Baseline 3 Minute 5 Minute Baseline 
 
Baseline Frequency Response 
 
 
0613JSB 0613JS3M1 0613JS5M2 
0.906 
1.436 
1.848 
2.213 
2.433 
2.533 
2.380 
1.863 
1.549 
1.400 
0.969 
0.930 
0.857 
 
 
2.746 
3.051 
2.746 
2.288 
2.441 
2.899 
2.746 
2.441 
2.593 
2.288 
2.441 
2.441 
2.441 
2.441 
2.746 
2.746 
2.746 
2.441 
2.288 
2.288 
2.441 
2.288 
2.288 
2.136 
2.441 
2.746 
2.593 
2.593 
2.899 
2.136 
2.441 
2.288 
 
2.746 
2.899 
3.051 
2.899 
2.746 
2.746 
2.746 
3.051 
2.899 
3.204 
2.746 
3.204 
3.051 
3.204 
3.204 
3.356 
2.746 
2.899 
2.899 
3.204 
2.746 
2.899 
3.204 
2.899 
2.899 
2.746 
2.593 
2.899 
3.356 
3.051 
2.746 
 
3 Minute 
 
 
5 Minute 
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Student 16: 0613MB 
Peak-to-Peak Data Graph 
Baseline 3 Minute 5 Minute Baseline 
 
Baseline Frequency Response 
 
 
0613MBB 0613MB3M2 0613MB5M1 
0.907 
0.878 
1.133 
1.266 
1.387 
1.553 
1.566 
1.721 
1.945 
1.290 
1.115 
0.663 
0.735 
0.589 
0.626 
 
2.441 
1.983 
2.136 
1.831 
1.831 
2.136 
1.983 
1.983 
2.288 
1.983 
2.136 
2.136 
2.136 
2.136 
2.136 
2.136 
2.288 
2.136 
2.441 
2.288 
2.136 
2.288 
2.136 
1.831 
1.983 
2.136 
1.983 
2.136 
1.983 
1.983 
1.983 
1.831 
1.983 
1.983 
2.136 
1.831 
1.983 
1.831 
1.831 
 
1.983 
2.136 
1.983 
2.136 
1.831 
2.136 
1.831 
1.831 
1.831 
1.983 
1.983 
2.136 
1.983 
1.831 
1.983 
1.831 
1.678 
1.678 
1.678 
1.678 
1.831 
2.136 
1.983 
1.983 
1.983 
2.136 
1.831 
2.136 
1.831 
2.136 
2.441 
1.983 
2.136 
1.831 
2.288 
1.678 
1.678 
2.441 
2.136 
2.136 
2.136 
1.983 
1.831 
1.983 
1.983 
1.983 
 
 
3 Minute 
 
 
5 Minute 
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Student 17: 0613MP 
Peak-to-Peak Data Graph 
Baseline 3 Minute 5 Minute Baseline 
 
Baseline Frequency Response 
 
 
0613MPB 0613MP3M1 0613MP5M2 
2.156 
3.206 
3.056 
3.287 
2.595 
1.873 
1.651 
1.272 
1.188 
0.911 
0.920 
 
2.441 
2.288 
2.288 
2.441 
2.593 
2.136 
2.899 
2.593 
2.441 
2.593 
2.746 
2.593 
2.288 
2.746 
2.746 
3.051 
3.051 
3.051 
2.746 
2.899 
2.441 
2.746 
3.051 
2.746 
2.593 
2.899 
2.746 
2.746 
 
3.051 
2.593 
3.051 
3.051 
2.746 
3.204 
4.272 
3.051 
3.509 
3.204 
3.051 
2.593 
2.593 
3.051 
2.899 
2.746 
2.136 
2.136 
3.051 
2.899 
2.746 
2.441 
2.746 
2.746 
2.593 
2.593 
2.746 
2.593 
3.051 
2.593 
2.593 
 
3 Minute 
 
 
5 Minute 
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Student 18: 0613MPO 
Peak-to-Peak Data Graph 
Baseline 3 Minute 5 Minute Baseline 
 
Baseline Frequency Response 
 
 
0613MPOB 0613MPO3M2 0613MPO5M1 
1.210 
1.448 
1.459 
1.773 
1.917 
1.545 
1.251 
0.958 
0.877 
 
 
2.288 
2.593 
2.288 
2.441 
1.831 
1.983 
1.983 
2.288 
2.441 
2.441 
2.593 
2.288 
2.288 
2.441 
2.593 
2.441 
2.441 
2.441 
2.441 
1.983 
2.441 
2.593 
2.136 
2.593 
2.441 
2.288 
2.288 
2.441 
2.288 
2.441 
2.136 
2.136 
2.136 
1.983 
2.288 
2.288 
2.746 
2.593 
2.288 
 
2.593 
2.593 
2.288 
2.136 
2.136 
2.441 
2.288 
2.441 
2.441 
2.441 
2.593 
2.441 
2.288 
2.746 
2.746 
2.441 
2.288 
2.593 
2.441 
2.441 
2.136 
2.136 
2.899 
2.441 
2.899 
2.593 
2.441 
2.746 
2.288 
2.288 
2.441 
2.593 
2.593 
2.593 
2.288 
2.288 
2.593 
2.593 
2.441 
 
 
3 Minute 
 
 
5 Minute 
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Student 19: 0613MS 
Peak-to-Peak Data Graph 
Baseline 3 Minute 5 Minute Baseline 
 
Baseline Frequency Response 
 
 
0613MSB 0613MS3M1 0613MS5M2 
0.799 
1.146 
1.357 
1.487 
1.558 
1.461 
1.201 
0.779 
 
 
2.136 
1.831 
1.678 
1.831 
1.525 
1.831 
1.678 
1.525 
1.983 
1.678 
1.678 
1.525 
1.678 
1.678 
1.678 
1.678 
1.983 
1.678 
1.831 
1.831 
1.983 
1.983 
1.831 
1.525 
1.525 
1.831 
1.831 
 
2.136 
1.678 
1.831 
1.525 
1.220 
1.678 
1.525 
1.831 
1.678 
1.525 
2.288 
1.831 
1.983 
1.678 
1.525 
1.678 
1.525 
1.525 
1.525 
1.678 
1.220 
1.525 
1.525 
1.220 
1.373 
1.678 
1.678 
2.288 
2.136 
1.373 
1.831 
1.831 
1.678 
 
3 Minute 
 
 
5 Minute 
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Student 20: 0613NN 
Peak-to-Peak Data Graph 
Baseline 3 Minute 5 Minute Baseline 
 
Baseline Frequency Response 
 
 
0613NNB 0613NN3M1 0613NN5M2 
0.878 
1.247 
1.382 
1.751 
1.066 
0.639 
0.525 
0.577 
 
 
2.441 
1.983 
2.136 
1.678 
1.983 
1.525 
1.831 
1.831 
2.136 
2.136 
2.441 
1.831 
1.831 
1.525 
1.678 
1.831 
1.373 
1.373 
1.678 
1.983 
2.136 
1.831 
2.288 
2.136 
1.983 
2.136 
1.525 
1.678 
1.525 
1.678 
1.678 
1.678 
1.678 
1.831 
1.831 
1.983 
1.983 
2.136 
2.441 
2.136 
1.831 
1.983 
 
 
2.136 
2.136 
2.441 
1.983 
2.288 
2.136 
2.288 
2.593 
1.983 
1.983 
1.983 
1.983 
2.288 
1.983 
2.136 
1.983 
2.288 
2.136 
1.983 
1.831 
2.136 
2.288 
2.136 
1.983 
2.593 
2.288 
2.288 
1.983 
1.983 
1.983 
2.441 
2.136 
2.136 
1.983 
1.831 
2.441 
2.441 
2.288 
2.136 
2.136 
2.136 
2.136 
 
3 Minute 
 
 
5 Minute 
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Overall Means Data 
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Student 1: 0612BJ 
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Student 2: 0612BK 
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Student 3: 0612BP 
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Student 4: 0612EK 
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 Student 5: 0612GL 
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Student 6: 0612JF 
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Student 7: 0612JK 
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Student 8: 0612JL 
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Student 9: 0612KV 
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Student 10: 0612NB 
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Student 11: 0162PF 
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Student 12: 0612RK 
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Student 13: 0612SS 
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Student 14: 0613JL 
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Student 15: 0613JS 
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Student 16: 0613MB 
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Student 17: 0613MP 
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Student 18: 0613MPO 
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Student 19: 0613MS 
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Student 20: 0613NN 
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Age/Gender Study 
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Age/Gender Study (continued) 
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Combined Student Data 
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# GENDER AGE SBP DBP BPM 
CUFF 
TIGHT 
(CM) 
50 
SUPRA
SYSTO
LIC 
BASELIN
E 3 MINUTE 5 MINUTE 
1 M 21 129 67 76 14 179 0612JLB 0612JL3M2 0612JL5M1 
2 F 22 125 67 81 14 175 0612SSB 0612SS3M2 0612SS5M1 
3 F 22 117 76 94 13 167 0612EKB 0612EK3M2 0612EK5M1 
4 M 22 121 61 66 7 171 0612BKB 0612BK3M1 0612BK5M2 
5 M 25 119 66 75 10 169 0612JFB 0612JF3M1 0612JF5M2 
6 F 23 107 64 80 12.5 157 0612RKB 0612RK3M1 0612RK5M2 
7 F 21 112 66 80 13.5 162 0612JKB 0612JK3M2 0612JK5M1 
8 F 19 99 64 80 13.5 149 0612PFB 0612PF3M1 0612PF5M2 
9 F 18 117 66 101 11 167 0612KVB 0612KV3M2 0612KV5M1 
10 F 18 110 58 56 12 160 0612BPB 0612BP3M2 0612BP5M1 
11 M 23 149 95 102 1 199 0612BJB 0612BJ3M1 0612BJ5M2 
12 M 22 127 72 89 4 177 0612NBB 0612NB3M1 0612NB5M2 
13 M 22 137 79 77 9 187 0612GLB 0612GL3M2 0612GL5M1 
14 M 23 133 75 62 5.5 183 0613JLB 0613JL3M2 0612JL25M1 
15 F 23 128 74 86 11.5 178 0613MBB 0613MB3M2 0613MB5M1 
16 F 22 103 60 61 15 153 0613MPB 0613MP3M1 0613MP5M2 
17 F 23 121 71 84 13.5 171 0613MPOB 
0613MPO3M
2 0613MPO5M1 
18 F 22 122 80 88 12 172 0613NNB 0613NN3M1 0613NN5M2 
19 F 22 121 77 N/A  8.5 171 0613MSB 0613MS3M1 0613MS5M2 
20 M 27 107 59 61 12 157 0613JSB 0613JS3M1 0613JS5M2 	
